Larazotide acetate: a pharmacological peptide approach to tight junction regulation.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Larazotide acetate: a pharmacological peptide approach to tight junction regulation.
- Published In:
- American journal of physiology. Gastrointestinal and liver physiology, 320(6), G983-G989 (2021)
- Database ID:
- RPEP-05774
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05774APA
Slifer, Zachary M; Krishnan, B Radha; Madan, Jay; Blikslager, Anthony T. (2021). Larazotide acetate: a pharmacological peptide approach to tight junction regulation.. American journal of physiology. Gastrointestinal and liver physiology, 320(6), G983-G989. https://doi.org/10.1152/ajpgi.00386.2020
MLA
Slifer, Zachary M, et al. "Larazotide acetate: a pharmacological peptide approach to tight junction regulation.." American journal of physiology. Gastrointestinal and liver physiology, 2021. https://doi.org/10.1152/ajpgi.00386.2020
RethinkPeptides
RethinkPeptides Research Database. "Larazotide acetate: a pharmacological peptide approach to ti..." RPEP-05774. Retrieved from https://rethinkpeptides.com/research/slifer-2021-larazotide-acetate-a-pharmacological
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.